The oncogenic functions of hepsin are mainly linked to proteolytic activities that disrupt epithelial integrity, and it regulatorily interacts with cell-proliferation, EMT/metastasis, inflammatory, and tyrosine-kinase-signaling pathways, promoting cancer cell motility and metastasis. Here, HPN is linked to cancer.